Earnings Preview: PRA Health Sciences (PRAH) Q1 Earnings Expected to DeclineZacks Investment Research • 04/23/20
Symphony Health to provide free access to new MetysTM COVID-19 Module for U.S. based life sciences industry during pandemicGlobeNewsWire • 04/08/20
PRA Health Sciences expands remote clinical study support with its Mobile Health Platform during COVID-19 pandemicGlobeNewsWire • 03/24/20
Why Is PRA Health Sciences (PRAH) Down 39.4% Since Last Earnings Report?Zacks Investment Research • 03/21/20
Symphony Health Partners with Datavant for the Industry’s Deepest View of the Patient JourneyGlobeNewsWire • 03/11/20
PRA Health Sciences, Inc. (PRAH) CEO Colin Shannon on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/21/20
PRA Health Sciences (PRAH) Q4 Earnings and Revenues Top EstimatesZacks Investment Research • 02/20/20
PRA Health Sciences' (PRAH) CEO Colin Shannon on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 10/31/19
PRA Health Sciences (PRAH) Beats Q3 Earnings and Revenue EstimatesZacks Investment Research • 10/30/19
PRA Health Sciences (PRAH) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 10/23/19
PRA Health Sciences, Inc. Announces Pricing of Secondary Offering and Concurrent Share RepurchaseGlobeNewsWire • 09/04/19
PRA Health Sciences, Inc. Announces Secondary Offering and Concurrent Share RepurchaseGlobeNewsWire • 09/03/19
PRA Health Sciences annonce une alliance stratégique entre Symphony Health et Close-Up InternationalGlobeNewsWire • 08/20/19